Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology
Open Access
- 11 October 2004
- journal article
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 83 (1), 67-70
- https://doi.org/10.1111/j.1600-0420.2004.00336.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edemaAmerican Journal of Ophthalmology, 2003
- Intravitreal triamcinolone for refractory pseudophakic macular edemaAmerican Journal of Ophthalmology, 2003
- Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular EdemaAmerican Journal of Ophthalmology, 2003
- Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edemaJournal of Cataract & Refractive Surgery, 2003
- Intravitreal triamcinolone for refractory diabetic macular edemaOphthalmology, 2002
- Intravitreal triamcinolone and elevated intraocular pressureAustralian and New Zealand Journal of Ophthalmology, 1999
- The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-γ production by cultured primary CD4+ T cellsJournal of Allergy and Clinical Immunology, 1997
- Treatment With Intravitreal Steroid Reduces Blood-Retinal Barrier Breakdown due to Retinal PhotocoagulationAmerican Journal of Ophthalmology, 1992
- Photocoagulation for Diabetic Macular EdemaAmerican Journal of Ophthalmology, 1985
- Factors affecting pseudophakic cystoid macular edema: Five randomized trialsAmerican Intra-Ocular Implant Society Journal, 1985